紳漢機器人輔助手術在泌尿科領域中是可行的：新系統的初步經驗與異常排除

巫紹瑋¹、袁倫祥¹、黃鈺文¹、黃昭淵²、黃士維¹

¹國立台灣大學附設醫院雲林分院 泌尿部；²國立台灣大學附設醫院 泌尿部

The Senhance Robotic System is Feasible in Oncologic and Non-Oncologic Urologic Surgeries: Initial Experiences and Troubleshooting of New System

Shao-Wei Wu¹, Lun-Hsiang Yuan¹, Yu-Wen Huang¹, Chao-Yuan Huang², Shi-Wei Huang ¹

Department of Urology, National Taiwan University Hospital Yunlin Branch, Yunlin County, Taiwan¹; Departments of Urology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan²

Purpose:

The Senhance robotic system is a new surgical robotic platform. However, few studies on the Senhance robotic system in urology have been conducted. To demonstrate the feasibility and troubleshooting of the Senhance robotic system in urologic oncologic and non-oncologic surgeries.

Materials and Methods:

From July 2018 to Dec 2020, a total of 173 patients were recruited. The operations were classified as simple and complex according to surgery that requires reconstruction or not. Docking time was recorded. We used the Clavien-Dindo classification system to evaluate the complications that occurred within 30 days after surgery. Common technical and mechanical events encountered were also recorded.

Results:

The median age was 65(58-74) years old, the median ASA score was 2(73%), and the median BMI was 24.7(16.5-35.6) kg/m². Seventeen (9.8%) patients had previously undergone abdominal surgeries. Oncologic and non-oncologic surgeries account for 35.3% (61) and 64.7% (112), respectively. Forty-three (24.9%) cases were complex surgeries that requires reconstruction. The median docking time was 5(1-35) minutes. There were 28 cases (16.2%) with grade I complications and 9 cases (5.2%) with grade II complications. Only one case (0.6%) of grade IIIb complication occurred during radical prostatectomy. No grade IV complications or mortalities were noted. Robotic arm collisions and forces exceeding the limit were the most commonly encountered problems intraoperatively.

Conclusion:

In our initial experiences, the Senhance robotic system was feasible and reliable in oncologic and non-oncologic urologic surgeries and had acceptable outcomes. The haptic feedback system is unique and requires a learning period. This system may serve as an alternative tool for all robotic urologic surgeries.